Coral, a Canadian women’s digital health startup, has announced the successful completion of a $4.1 million CAD seed funding round. The financing was led by Brightspark, with participation from Diagram, The51, and several high-profile angel investors. With this investment, Coral aims to revolutionize menopause care by offering integrated, personalized virtual solutions for women experiencing perimenopause, menopause, and beyond.

Addressing a Long-Overlooked Health Concern

Menopause is a significant transition that affects nearly all women, with 95% experiencing symptoms that can persist for over a decade. Many women face debilitating health challenges during this stage, often without adequate medical support or treatment. Coral seeks to bridge this gap by providing accessible, evidence-based care to help women maintain their well-being and quality of life.

Experienced Leadership Driving Innovation

Coral was founded by Anna Chif, Fiona Lake Waslander, and John McCalla, a team with extensive experience in digital healthcare and technology. Anna Chif, serving as Chairwoman, previously co-founded Dialogue, Canada’s largest telemedicine provider, which went public in 2021 and was later acquired by Sunlife Financial in 2023. Together, the founding team is leveraging their expertise to scale Coral’s innovative model and bring comprehensive menopause care to the forefront of women’s health.

A Holistic and Personalized Approach

Coral’s virtual care platform offers a range of services designed to provide a complete picture of each woman’s health. The platform includes at-home blood testing, body composition scans, and detailed health assessments to deliver tailored care plans. Through dedicated nurses, medical doctors, and health coaches, Coral integrates medical guidance with lifestyle support in areas such as nutrition, fitness, and mental well-being.

Impact on Women’s Health and Workforce

Menopause symptoms can severely impact a woman’s daily life, with one in ten women leaving the workforce due to unmanaged health issues. As nearly half of the workforce consists of women, the lack of proper menopause care has broader economic and social implications. Coral’s initiative seeks to empower women to remain healthy and active during this crucial life stage, ultimately enhancing their overall productivity and quality of life.

Investor Confidence in Coral’s Vision

Leading investors have expressed strong confidence in Coral’s potential to redefine women’s healthcare. Sophie Forest, Partner at Brightspark Ventures, highlighted the team’s exceptional expertise in digital health and direct-to-consumer solutions, emphasizing the opportunity to transform a traditionally underserved sector. Gaurav Kapoor, General Partner at Diagram, echoed this sentiment, stating that Coral’s approach aligns with the firm’s commitment to investing in companies that drive meaningful change.

A Future of Innovation and Growth

With fresh funding in place, Coral is set to expand its reach and enhance its platform to support more women across Canada. The company’s long-term vision is to establish a new standard in menopause care, integrating cutting-edge technology with comprehensive medical and lifestyle solutions. By addressing a long-overlooked health issue, Coral aims to empower millions of women to lead healthier, more fulfilling lives.

Coral is a pioneering digital health platform dedicated to improving menopause care for women across Canada. By providing evidence-based treatments, holistic solutions, and a team-based medical approach, Coral ensures that women receive ongoing, personalized support. With a mission to transform menopause healthcare, Coral is setting a new benchmark for accessible and effective treatment solutions.